NCT04733157View on ClinicalTrials.gov

The Efficacy of Tranexamic Acid in Preventing Postpartum Haemorrhage After Caesarean Section

PHASE3CompletedINTERVENTIONAL
Enrollment

1,226

Participants

Timeline

Start Date

March 23, 2021

Primary Completion Date

December 14, 2021

Study Completion Date

December 14, 2021

Conditions
Postpartum Hemorrhage
Interventions
DRUG

Tranexamic acid injection

Tranexamic 1g administered intravenously at the onset of skin incision at caesarean section

OTHER

Normal saline placebo

10ml of normal saline will be administered intravenously at onset of skin incision at caesarean section to the placebo group

Trial Locations (2)

Unknown

Parirenyatwa Group of Hospitals (Mbuya Nehanda Maternity Hospital), Harare

Sally Mugabe Central Hospital Maternity Unit, Harare

All Listed Sponsors
collaborator

Fogarty International Center of the National Institute of Health

NIH

lead

University of Zimbabwe

OTHER

NCT04733157 - The Efficacy of Tranexamic Acid in Preventing Postpartum Haemorrhage After Caesarean Section | Biotech Hunter | Biotech Hunter